Abstract
In order to investigate the anti-proliferative effect of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, we evaluated the effects of lovastatin on DNA replication and the proliferation of rat mesangial and aortic smooth muscle cells, both of which were mesenchymal origin cells. Proliferations were determined by measuring [3H]thymidine uptake, and counting the number of cells. Growth-arrested mesangial and aortic smooth muscle cells were exposed to platelet-derived growth factor (PDGF), endothelin (ET) and angiotensin II (Ang II) to stimulate mitogenesis. All agents exhibited dose-dependent stimulation of [3H]thymidine uptake. PDGF was more potent than the others. Ang II increased [3H]thymidine uptake without demonstrable mitogenic activity. Lovastatin inhibited PDGF (10 ng/ml in mesangial cells, 25 ng/ml in smooth muscle cells)-, ET (10-7 M)- and Ang II (10-7 M)-induced [3H]thymidine uptake significantly in a dose-dependent manner in both cells. The increase of cell number in response to PDGF and ET treatment were also inhibited at 10 μM of lovastatin. The inhibitory effect of lovastatin was largely overcome in the presence of exogenous mevalonate at 200 μM, with 75.5% restoration from lovastatin-induced inhibition on PDGF-induced [3H]thymidine uptake in mesangial cells (77.8% in aortic smooth muscle cells). However, the addition of cholesterol did not prevent inhibition by lovastatin. In conclusion, lovastatin had an inhibitory effect on mesangial and aortic smooth muscle cell proliferation, and mevalonate was essential for DNA replication in both types of cells. Lovastatin may reduce glomerular and atherosclerotic injury through an anti-proliferative effect on mesangial and vascular smooth muscle cells, in addition to lowering circulating lipids.
| Original language | English |
|---|---|
| Pages (from-to) | 251-261 |
| Number of pages | 11 |
| Journal | Yonsei Medical Journal |
| Volume | 36 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 1995 Jan 1 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Medicine(all)
Cite this
}
The effect of lovastatin on proliferation of cultured rat mesangial and aortic smooth muscle cells. / Choi, K. H.; Kang, Shin-Wook; Lee, S. W.; Lee, H. Y.; Han, D. S.; Kang, B. S.
In: Yonsei Medical Journal, Vol. 36, No. 3, 01.01.1995, p. 251-261.Research output: Contribution to journal › Article
TY - JOUR
T1 - The effect of lovastatin on proliferation of cultured rat mesangial and aortic smooth muscle cells
AU - Choi, K. H.
AU - Kang, Shin-Wook
AU - Lee, S. W.
AU - Lee, H. Y.
AU - Han, D. S.
AU - Kang, B. S.
PY - 1995/1/1
Y1 - 1995/1/1
N2 - In order to investigate the anti-proliferative effect of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, we evaluated the effects of lovastatin on DNA replication and the proliferation of rat mesangial and aortic smooth muscle cells, both of which were mesenchymal origin cells. Proliferations were determined by measuring [3H]thymidine uptake, and counting the number of cells. Growth-arrested mesangial and aortic smooth muscle cells were exposed to platelet-derived growth factor (PDGF), endothelin (ET) and angiotensin II (Ang II) to stimulate mitogenesis. All agents exhibited dose-dependent stimulation of [3H]thymidine uptake. PDGF was more potent than the others. Ang II increased [3H]thymidine uptake without demonstrable mitogenic activity. Lovastatin inhibited PDGF (10 ng/ml in mesangial cells, 25 ng/ml in smooth muscle cells)-, ET (10-7 M)- and Ang II (10-7 M)-induced [3H]thymidine uptake significantly in a dose-dependent manner in both cells. The increase of cell number in response to PDGF and ET treatment were also inhibited at 10 μM of lovastatin. The inhibitory effect of lovastatin was largely overcome in the presence of exogenous mevalonate at 200 μM, with 75.5% restoration from lovastatin-induced inhibition on PDGF-induced [3H]thymidine uptake in mesangial cells (77.8% in aortic smooth muscle cells). However, the addition of cholesterol did not prevent inhibition by lovastatin. In conclusion, lovastatin had an inhibitory effect on mesangial and aortic smooth muscle cell proliferation, and mevalonate was essential for DNA replication in both types of cells. Lovastatin may reduce glomerular and atherosclerotic injury through an anti-proliferative effect on mesangial and vascular smooth muscle cells, in addition to lowering circulating lipids.
AB - In order to investigate the anti-proliferative effect of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, we evaluated the effects of lovastatin on DNA replication and the proliferation of rat mesangial and aortic smooth muscle cells, both of which were mesenchymal origin cells. Proliferations were determined by measuring [3H]thymidine uptake, and counting the number of cells. Growth-arrested mesangial and aortic smooth muscle cells were exposed to platelet-derived growth factor (PDGF), endothelin (ET) and angiotensin II (Ang II) to stimulate mitogenesis. All agents exhibited dose-dependent stimulation of [3H]thymidine uptake. PDGF was more potent than the others. Ang II increased [3H]thymidine uptake without demonstrable mitogenic activity. Lovastatin inhibited PDGF (10 ng/ml in mesangial cells, 25 ng/ml in smooth muscle cells)-, ET (10-7 M)- and Ang II (10-7 M)-induced [3H]thymidine uptake significantly in a dose-dependent manner in both cells. The increase of cell number in response to PDGF and ET treatment were also inhibited at 10 μM of lovastatin. The inhibitory effect of lovastatin was largely overcome in the presence of exogenous mevalonate at 200 μM, with 75.5% restoration from lovastatin-induced inhibition on PDGF-induced [3H]thymidine uptake in mesangial cells (77.8% in aortic smooth muscle cells). However, the addition of cholesterol did not prevent inhibition by lovastatin. In conclusion, lovastatin had an inhibitory effect on mesangial and aortic smooth muscle cell proliferation, and mevalonate was essential for DNA replication in both types of cells. Lovastatin may reduce glomerular and atherosclerotic injury through an anti-proliferative effect on mesangial and vascular smooth muscle cells, in addition to lowering circulating lipids.
UR - http://www.scopus.com/inward/record.url?scp=0029152798&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029152798&partnerID=8YFLogxK
U2 - 10.3349/ymj.1995.36.3.251
DO - 10.3349/ymj.1995.36.3.251
M3 - Article
VL - 36
SP - 251
EP - 261
JO - Yonsei Medical Journal
JF - Yonsei Medical Journal
SN - 0513-5796
IS - 3
ER -